Earnings News
FONT-SIZE Plus   Neg

Roche Q1 Group Sales Rise; Backs 2012 Outlook - Quick Facts

Roche Holding AG (RHHBY.PK) said its first-quarter group sales rose 2% at constant exchange rates to 11.03 billion Swiss francs from a year ago. Excluding Tamiflu, sales growth is 3%. Sales were down 1% in Swiss francs, while it was up 1% in US dollars.

Roche also confirmed its full-year outlook for 2012. Barring unforeseen events, Roche still expects low to mid-single-digit sales growth at constant exchange rates for the Group and the Pharmaceuticals Division in 2012.

Despite a challenging market environment, based on the expected sales growth and continued efficiency improvements, Roche continues to aim for a high single-digit increase in Core Earnings per Share at constant exchange rates.

Click here to receive FREE breaking news email alerts for Roche Holding AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
FREE Newsletters, Analysis & Alerts


Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.